Accelerated cisplatin and high-dose epirubicin with G-CSF support in patients with relapsed non-small-cell lung cancer: feasibility and efficacy

The purpose of this study is to determine whether it is feasible to administer high-dose epirubicin (135 mg m(−2)) combined with a fixed dose of cisplatin every 2 weeks with G-CSF support in patients with metastatic non-small-cell lung cancer (NSCLC). Subsequently, the efficacy of the recommended do...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Huisman, C, Biesma, B, Postmus, P E, Giaccone, G, Schramel, F M N H, Smit, E F
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363962/
https://ncbi.nlm.nih.gov/pubmed/11720428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2001.2013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados